Loading...
Current and Emerging Targeted Therapies for Acute Graft versus Host Disease
Acute graft-versus-host disease (GVHD), the major complication after allogeneic hematopoietic cell transplant (HCT), develops in approximately 50% of patients. The primary treatment is high dose systemic steroids, but treatment failure is common and steroid-refractory (SR) GVHD is the leading cause...
Saved in:
| Published in: | BioDrugs |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2021
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7855093/ https://ncbi.nlm.nih.gov/pubmed/33201499 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40259-020-00454-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|